GE HealthCare Technologies Inc. carries a market capitalization of 28.22B, placing it among publicly traded companies globally. Its enterprise value stands at 41.02B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 28.22B |
| Enterprise Value | 41.02B |
GE HealthCare Technologies Inc. currently has 454.89M shares outstanding.
| Shares Outstanding | 454.89M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
GE HealthCare Technologies Inc. trades at a trailing price-to-earnings ratio of 17.00. The price-to-sales ratio is 1.55, and the price-to-book ratio stands at 5.74.
| PE Ratio | 17.00 |
| PS Ratio | 1.55 |
| PB Ratio | 5.74 |
| P/TBV Ratio | -5.35 |
| P/FCF Ratio | 12.84 |
| P/OCF Ratio | 16.02 |
On an enterprise value basis, GE HealthCare Technologies Inc. trades at an EV/EBITDA multiple of 12.65 and an EV/FCF ratio of 14.34. The EV/Sales ratio of 1.96 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 15.49 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.96 |
| EV / EBITDA | 12.65 |
| EV / EBIT | 15.49 |
| EV / FCF | 14.34 |
GE HealthCare Technologies Inc. maintains a current ratio of 1.22, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 97.05, indicating elevated leverage, while an interest coverage ratio of 7.62 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.22 |
| Quick Ratio | 0.82 |
| Debt / Equity | 97.05 |
| Debt / EBITDA | 3.26 |
| Interest Coverage | 7.62 |
GE HealthCare Technologies Inc. posts a return on equity of 40.32 and a return on invested capital of 9.99.
| Return on Equity (ROE) | 40.32 |
| Return on Assets (ROA) | 5.40 |
| Return on Invested Capital (ROIC) | 9.99 |
| Return on Capital Employed (ROCE) | 14.61 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 5.66 |
Over the trailing twelve months, GE HealthCare Technologies Inc. has paid 605.00M in income taxes, reflecting an effective tax rate of 23.43.
| Income Tax | 605.00M |
| Effective Tax Rate | 23.43 |
GE HealthCare Technologies Inc.'s stock has declined approximately -12.79348% over the past 52 weeks. The 50-day moving average sits at 67.13, while the 200-day moving average is 75.24.
| Beta (5Y) | N/A |
| 52-Week Price Change | -12.79348% |
| 50-Day Moving Average | 67.13 |
| 200-Day Moving Average | 75.24 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, GE HealthCare Technologies Inc. generated 20.98B in revenue and converted that into 1.91B in net income, yielding earnings per share of 4.32. EBITDA reached 3.24B, while operating income came in at 2.65B.
| Revenue | 20.98B |
| Gross Profit | 8.21B |
| Operating Income | 2.65B |
| Pretax Income | 2.58B |
| Net Income | 1.91B |
| EBITDA | 3.24B |
| EBIT | 2.65B |
| Earnings Per Share (EPS) | 4.32 |
GE HealthCare Technologies Inc. holds 2.26B in cash and equivalents against 10.58B in total debt, resulting in a net debt position of 7.87B. Total book value stands at 5.66B, with working capital of 1.90B providing operational flexibility.
| Cash & Cash Equivalents | 2.26B |
| Total Debt | 10.58B |
| Net Debt | 7.87B |
| Equity (Book Value) | 5.66B |
| Book Value Per Share | 12.40 |
| Working Capital | 1.90B |
GE HealthCare Technologies Inc. produced 2.03B in operating cash flow over the past twelve months. After subtracting -508.00M in capital expenditures, free cash flow totaled 1.52B - equivalent to 3.33 per share.
| Operating Cash Flow | 2.03B |
| Capital Expenditures | -508.00M |
| Free Cash Flow | 1.52B |
| FCF Per Share | 3.33 |
GE HealthCare Technologies Inc. operates with a gross margin of 39.14, reflecting its pricing power and cost economics. The operating margin of 12.63 and net profit margin of 9.10 provide insight into operational efficiency.
| Gross Margin | 39.14 |
| Operating Margin | 12.63 |
| Pretax Margin | 12.31 |
| Profit Margin | 9.10 |
| EBITDA Margin | 15.46 |
The company's payout ratio of 3.13 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.14 |
| Dividend Yield | N/A |
| Payout Ratio | 3.13 |
| Shareholder Yield | -2.85 |
| FCF Yield | 7.79 |
GE HealthCare Technologies Inc. posts an Altman Z-Score of 2.72, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.72 |